See the factory by live video walkthrough
Book an on-site factory visit in Guangzhou
When you see “ophthalmologist-tested” on an eye cream or mascara, it signals that a medical eye specialist supervised or reviewed a safety study. But the phrase doesn’t tell you what the study actually measured,…
When you see “ophthalmologist-tested” on an eye cream or mascara, it signals that a medical eye specialist supervised or reviewed a safety study. But the phrase doesn’t tell you what the study actually measured, how many subjects were involved, or whether the results support your specific product claims. For brand owners and product developers, understanding the study design, realistic budgets, and the limits of marketing language is essential before you invest in clinical testing.
There is no formal FDA definition for “ophthalmologist-tested.” The claim generally means:
It does not automatically imply:
This is the most common study type to support “ophthalmologist-tested.” It’s an open-label, single-group trial where subjects use the product at home for 2 to 4 weeks, with in-clinic visits at baseline, interim, and end of study. An ophthalmologist performs slit-lamp exams, rates conjunctival and lid irritation, and checks for corneal staining. Subjective comfort questionnaires are also collected.
If you want to claim “equivalent to a leading brand” or “non-irritating in a sensitive population,” a controlled design is needed. This may involve a parallel group or a split-face design for products applied around the eye. Sample size increases (60–100+), along with statistical analysis plans.
A small proof-of-concept test with 10–20 subjects can screen for obvious tolerance issues before committing to a full claim-support study. These are faster and less expensive but carry more regulatory risk if used as sole support for marketing claims.
Cost estimates vary by geography, clinical site fees, ophthalmologist honoraria, and report writing. The table below gives rough ranges for U.S.-based studies.
| Study Type | Typical Cost Range | Main Variables |
|---|---|---|
| Pilot tolerance test (n=20) | $15,000 – $25,000 | Single site, 1 ophthalmologist, basic report |
| Standard 4-week safety-in-use (n=30–50) | $35,000 – $65,000 | Subject Screening, slit-lamp exams x3, statistics |
| Controlled comparative study (n=60–80) | $60,000 – $100,000+ | Randomization, blinding, multiple sites, full CRO fees |
| Contact lens wear compatibility add-on | Add $10,000 – $20,000 | Recruitment of lens wearers, lens-specific assessments |
Always budget an extra 15–20% for protocol amendments, statistical analysis, and the final clinical study report (CSR). If the formulation changes after testing, the study may not support the new version — plan your R&D timeline to freeze the formula before the definitive study.
To back up the “ophthalmologist-tested” claim, your CSR should include:
This documentation is what regulators and retailers (e.g., Amazon, Sephora) may request during a claims audit.
In the U.S., the FTC generally expects that a clinical test supporting a safety claim is statistically powered and represents the intended use population. A pilot test on 10 subjects will not hold up if challenged. Avoid “free claims” that a competitor or consumer group could easily protest.
When you contact a contract research organization (CRO), provide a clear request. A thorough RFP will help you get comparable quotes.
If you are working with a manufacturer like Laeyo Labs, in-house regulatory and R&D teams often have established relationships with ophthalmology CROs. This integration can shorten start-up timelines and reduce costs.
Not exactly. “Clinically tested” is broader and may not involve a physician. “Ophthalmologist-tested” specifically requires a board-certified eye doctor’s involvement in the study.
No. The claim must be based on a study of your finished product. Ingredient safety data alone is not sufficient to claim “ophthalmologist-tested” for the product.
There is no set expiry, but best practice is to generate new data if the formulation, manufacturing process, or packaging changes. Even a preservative switch can alter compatibility.
If the U.S. is your primary market, a U.S.-based ophthalmologist and IRB add credibility. Studies conducted abroad may still be valid, but you must ensure they meet U.S. standards and the ophthalmologist’s credentials are recognized.
Ready to develop an ophthalmologist-tested eye care product with a science-first partner? Request a Quote and our team will guide you through the study design, formulation, and regulatory support your brand needs.
With more than 20 years of experience in OEM/ODM/Private Label Cosmetics, I'd love to share valuable knowledge related to cosmetics & skincare products from a top-tier Chinese supplier's perspective.
